JAK / Stat

产品 201 到 229 共 229个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

设置升序顺序
  1. Lazertinib (YH25448,GNS-1480)

    Catalog No. A16827
    Quick View
    EGFR 抑制剂
    Lazertinib (YH25448,GNS-1480)是一种有效的,高度突变选择性和不可逆的EGFR-TKI,对于Del19/T790M,L858R/T790M,Del19,Del19,IC50值分别为1.7 nM,2 nM,5 nM,20.6 nM和76 nM。L85R和野生型EGFR分别显示出更高的IC50值,即抗药性ErbB2和ErbB4。 了解更多
  2. Tyrphostin AG-528

    Catalog No. A17072
    Quick View
    EGFR 抑制剂
    Tyrphostin AG-528,也称为Tyrphostin B66,是EGFR蛋白酪氨酸激酶抑制剂。 了解更多
  3. Pyrotinib Racemate

    Catalog No. A17068
    Quick View
    EGFR/HER2 dual 抑制剂
    Pyrotinib Racemate是吡罗替尼的外消旋体。吡罗替尼是一种有效的选择性EGFR/HER2双重抑制剂。 了解更多
    • 最新产品

    AG-494

    Catalog No. A17142
    Quick View
    EGFR 抑制剂
    AG-494是表皮生长因子受体激酶的抑制剂,在HT-22细胞中的IC50值为1μM。 了解更多
  4. Lavendustin A

    Catalog No. A17119
    Quick View
    EGFR 抑制剂
    Lavendustin A是表皮生长因子(EGF)受体相关酪氨酸激酶的选择性抑制剂,IC50值为11 nM。 了解更多
  5. AG-99

    Catalog No. A17123
    Quick View
    EGFR 抑制剂
    AG-99是一种表皮生长因子受体(EGFR)激酶抑制剂,IC50值为10μM。 了解更多
  6. AG 555

    Catalog No. A18337
    Quick View
    EGFR 抑制剂
    AG555 is a potent epidermal growth factor receptor (EGFR) kinase inhibitor. 了解更多
  7. RG14620

    Catalog No. A18327
    Quick View
    EGFR 抑制剂
    RG14620 is an EGFR inhibitor with an IC50 of 3 μM. 了解更多
  8. MTX-211

    Catalog No. A18324
    Quick View
    EGFR/PI3K 双重抑制剂
    MTX-211 is a dual inhibitor of EGFR and PI3K, which plays important roles in the progression of KRAS mutant colorectal cancer. MTX-211 has the potential for the treatment of KRAS mutant colorectal cancer. 了解更多
  9. DBPR112

    Catalog No. A18857
    Quick View
    EGFR 抑制剂
    DBPR112 is an orally active Furanopyrimidine-Based Epidermal Growth Factor Receptor inhibitor with IC50s of 15 nM and 48 nM for EGFRWT and EGFRL858R/T790M, respectively. 了解更多
  10. EGFR-IN-7

    Catalog No. A18562
    Quick View
    EGFR 抑制剂
    EGFR-IN-7 (compound 34) is a selective and potent EGFR kinase inhibitor extracted from patent WO2019015655A1, has IC50s of 7.92 nM and 0.218 nM for EGFR (WT) and EGFR (mutant C797S/T790M/L858R) respectively, and shows anti-tumor activity. 了解更多
  11. Mutated EGFR-IN-2

    Catalog No. A18565
    Quick View
    EGFR 抑制剂
    Mutated EGFR-IN-2 (compound 91) is a mutant-selective EGFR inhibitor extracted from patent WO2017036263A1, which potently inhibits single-mutant EGFR (T790M) and double-mutant EGFR (including L858R/T790M (IC50=??1nM) and ex19del/T790M), and can suppress activity of single gain-of-function mutant EGFR (including L858R and ex19del) as well. Mutated EGFR-IN-2 shows anti-tumor antivity. 了解更多
  12. Genistein

    Catalog No. A10425
    Quick View
    EGFR inhibitor
    Genistein, a soy isoflavone, is a multiple tyrosine kinases (e.g., EGFR) inhibitor which acts as a chemotherapeutic agent against different types of cancer, mainly by altering apoptosis, the cell cycle, and angiogenesis and inhibiting metastasis. 了解更多
  13. NSC 228155

    Catalog No. A16638
    Quick View
    EGFR activator
    NSC 228155 is an activator of EGFR, binds to the extracellular region of EGFR and enhance tyrosine phosphorylation of EGFR. 了解更多
  14. Epertinib

    Catalog No. A13777
    Quick View
    EGFR/HER2/HER4 inhibitor
    Epertinib is a potent, oral, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4, with IC50s of 1.48 nM, 7.15 nM and 2.49 nM, respectively. Epertinib shows potent antitumor activity. 了解更多
  15. EGFR-IN-2

    Catalog No. A12628
    Quick View
    EGFR inhibitor
    EGFR-IN-2 is a a noncovalent, irreversible, mutant-selective second generation EGFR inhibitor. 了解更多
  16. CHMFL-EGFR-202

    Catalog No. A12524
    Quick View
    EGFR inhibitor
    CHMFL-EGFR-202 is a potent, irreversible inhibitor of epidermal growth factor receptor (EGFR) mutant kinase, with IC50s of 5.3 nM and 8.3 nM for drug-resistant mutant EGFR T790M and WT EGFR kinases, respectively. 了解更多
  17. EGFR-IN-3

    Catalog No. A15847
    Quick View
    EGFR inhibitor
    EGFR-IN-3 is an epidermal growth factor receptor (EGFR) inhibitor. 了解更多
  18. Canertinib dihydrochloride

    Catalog No. A11344
    Quick View
    EGFR inhibitor
    Canertinib dihydrochloride (CI-1033 dihydrochloride) is a potent and irreversible EGFR inhibitor; inhibits cellular EGFR and ErbB2 autophosphorylation with IC50s of 7.4 and 9 nM. 了解更多
  19. Afatinib

    Catalog No. A18014
    Quick View
    EGFR inhibitor
    Afatinib (BIBW 2992) is an irreversible EGFR family inhibitor with IC50s of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively. 了解更多
  20. Tarloxotinib bromide

    Catalog No. A20849
    Quick View
    EGFR/HER2 inhibitor
    Tarloxotinib bromide (TH-4000) is an irreversible EGFR/HER2 inhibitor. 了解更多
  21. Mutant EGFR inhibitor

    Catalog No. A21144
    Quick View
    EGFR inhibitor
    Mutant EGFR inhibitor is a potent and selective mutant EGFR inhibitor extracted from patent WO 2013014448 A1; inhibits EGFRL858R, EGFRExon 19 deletion and EGFRT790M. 了解更多
  22. HS-10296 hydrochloride

    Catalog No. A21661
    Quick View
    EGFR/T790M inhibitor
    HS-10296 hydrochloride is an orally available and third-Generation inhibitor of epidermal growth factor receptor (EGFR)-activating mutations and T790M-resistant mutation with limited activity against wild-type EGFR. 了解更多
  23. AST2818 mesylate

    Catalog No. A21666
    Quick View
    EGFR inhibitor
    AST2818 mesylate is an EGFR inhibitor. 了解更多
  24. Nazartinib mesylate

    Catalog No. A21741
    Quick View
    covalent mutant-selective EGFR inhibitor
    Nazartinib mesylate (EGF816 mesylate) is a novel, covalent mutant-selective EGFR inhibitor, with Ki and Kinact of 31 nM and 0.222 min?1 on EGFR(L858R/790M) mutant, respectively. 了解更多
  25. Nazartinib S-enantiomer

    Catalog No. A21747
    Quick View
    EGFR inhibitor
    Nazartinib S-enantiomer (EGF816 S-enantiomer) is the less active S-enantiomer of Nazartinib. Nazartinib (EGF816) is an EGFR inhibitor. 了解更多
  26. Pyrotinib dimaleate

    Catalog No. A21756
    Quick View
    EGFR/HER2 dual inhibitor
    Pyrotinib dimaleate (SHR-1258 dimaleate) is a potent and selective EGFR/HER2 dual inhibitor with IC50 s of 13 and 38 nM, respectively. 了解更多
  27. Epertinib hydrochloride

    Catalog No. A21950
    Quick View
    EGFR, HER2 and HER4 inhibitor
    Epertinib hydrochloride is a potent, orally active, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4, with IC50s of 1.48 nM, 7.15 nM and 2.49 nM, respectively. Epertinib shows potent antitumor activity. 了解更多
  28. Lifirafenib

    Catalog No. A20988
    Quick View
    Raf/EGFR inhibitor
    Lifirafenib (BGB-283) is a novel and potent Raf Kinase and EGFR inhibitor with IC50 values of 23 and 29 nM for recombinant BRafV600E and EGFR, respectively. 了解更多

产品 201 到 229 共 229个

每页
页面:
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

设置升序顺序
Rewards